Sebaceous Hyperplasia Clinical Trial
Official title:
Treatment of Sebaceous Hyperplasia With PDL and Nd:YAG Versus Erbium:YAG: A Randomized Controlled Trial
The purpose of this study is to compare treatment of sebaceous hyperplasia with pulsed dye laser (PDL) plus neodymium doped yttrium aluminum garnet laser (Nd:YAG) versus erbium doped yttrium aluminum garnet (erbium:YAG) laser versus electrodesiccation and curettage (ED&C). This is a randomized clinical trial. Approximately 18 participants will enrolled. Each participant will have their sebaceous hyperplasia lesions randomized to receive either Erbium:YAG, PDL plus Nd:YAG, or ED&C treatment. Solitary lesions will be randomized to a group, thus, a patient may receive all three treatments, each on different lesions. Lesions will be treated twice, 2-6 weeks after the first treatment. Lesion size and count will be measured before treatment and at follow-up 4-12 weeks after the first treatment. This study is a pilot study designed to determine the feasibility of these procedures. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04539886 -
Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) Lesions
|
N/A | |
| Completed |
NCT03612570 -
Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia
|
N/A | |
| Terminated |
NCT04253418 -
Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization Study
|
N/A |